Mr. Immelt will share how improving healthcare is central to future competitiveness. He will discuss the role of innovation in breaking through the barriers of cost, quality and access and share his thoughts on sustaining healthcare and innovation in meaningful ways. His comments will be followed with a conversation with Maria Bartiromo.
Introduction: Delos "Toby" Cosgrove, MD
Moderator: Maria Bartiromo, Anchor, CNBC
Jeffrey Immelt, Chairman and Chief Executive Officer, General Electric
A discussion on the key scientific challenges driving the world of cardiovascular care.
Ferid, Murad, MD, PhD, Nobel Laureate and Professor, George Washington University
Bruce Lytle, MD
Chair, Heart and Vascular Institute, Cleveland Clinic
Perspectives from the Top of Industry
Leaders of some of the most influential organizations in healthcare provide their unique outlook on the current challenges and strengths of the healthcare industry, the climate for innovation, where we are, and where we are headed.
Ursula Burns, Chief Executive Officer, Xerox
Delos "Toby" Cosgrove, MD
Harry Rein, General Partner, Foundation Medical Partners
John Sheets, PhD, Senior Vice President, Corporate Research, Boston Scientific
Dan Starks, Chief Executive Officer, St. Jude Medical
Moderator: Paul Begala, Political Analyst and Commentator, CNN and Columnist, Newsweek and The Daily Beast
Rarely has medical innovation played such a central role in US elective politics. This bipartisan panel of top former elected officials and strategists will discuss how healthcare innovation will play out in the 2012 election and beyond.
Ray Gilmartin, Harvard Business School
Ezra Klein, Columnist, The Washington Post
Gail Wilensky, PhD, Senior Fellow, Project HOPE
CEO, Direct Flow Medical
Director, Division of Cardiovascular Devices, US FDA
CSO, Cordis Corporation
CEO, The Medicines Company
CEO, St. Jude Medical
Former US Vice President
St. Jude Medical
The Washington Post
CEO, Thoratec Corporation
National Patient Advocate Foundation
Foundation Medical Partners
Hogan Lovells US LLP
CEO, Cleveland Heart Lab
CEO, General Electric
CEO, Edwards Lifesciences
Novartis Venture Funds
Acting Director, Center for Medicare and Medicaid Innovation
President, Abbott Vascular
Chief Science and Health Correspondent, NBC
CEO, Real Points
CEO, C.R. Bard
Immelt likes equations almost as much as I like graphs. For health care, it's "cost = usage x price(inflation)." Implication: To tackle cost, you either need to get usage down, by making people healthier or restricting access, or get prices down, either through price controls or innovation.
The rate of medical innovation in the United States has fallen behind global competitors as manufacturers and investors struggle to work through inefficient regulatory processes, said medical industry and manufacturing leaders speaking at a Cleveland Clinic conference Oct. 3.
It's a gathering of technology, medicine and business that over the years has grown in international stature. Now in its ninth year, the assemblage will include machine matching wits with man and various arms of industry associations and competing businesses appearing -- in some cases, for the first time -- side by side.